Krause Kevin Michael bought ANTX
January 9, 2024 · Form 4 insider transaction
Krause Kevin Michael bought 5,000 shares of AN2 Therapeutics, Inc. at $6.60 per share, a transaction worth $33.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,000
Price
$6.60
Total value
$33.0K
InsiderKrause Kevin Michael
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 9, 2024
Filing dateJanuary 11, 2024
Shares owned after9,331
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 28, 2023.